BSX
Price
$97.32
Change
+$1.10 (+1.14%)
Updated
Oct 3 closing price
Capitalization
144.2B
16 days until earnings call
ICCM
Price
$0.96
Change
-$0.03 (-3.03%)
Updated
Oct 3 closing price
Capitalization
66.46M
50 days until earnings call
Interact to see
Advertisement

BSX vs ICCM

Header iconBSX vs ICCM Comparison
Open Charts BSX vs ICCMBanner chart's image
Boston Scientific
Price$97.32
Change+$1.10 (+1.14%)
Volume$10.77M
Capitalization144.2B
IceCure Medical
Price$0.96
Change-$0.03 (-3.03%)
Volume$17.61M
Capitalization66.46M
BSX vs ICCM Comparison Chart in %
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. ICCM commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a StrongBuy and ICCM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (BSX: $97.32 vs. ICCM: $0.96)
Brand notoriety: BSX: Notable vs. ICCM: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BSX: 124% vs. ICCM: 1005%
Market capitalization -- BSX: $144.2B vs. ICCM: $66.46M
BSX [@Medical/Nursing Services] is valued at $144.2B. ICCM’s [@Medical/Nursing Services] market capitalization is $66.46M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $234.25B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whileICCM’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • ICCM’s FA Score: 0 green, 5 red.
According to our system of comparison, BSX is a better buy in the long-term than ICCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while ICCM’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 5 bearish.
  • ICCM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BSX is a better buy in the short-term than ICCM.

Price Growth

BSX (@Medical/Nursing Services) experienced а -0.88% price change this week, while ICCM (@Medical/Nursing Services) price change was -5.49% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.81%. For the same industry, the average monthly price growth was +5.78%, and the average quarterly price growth was +19.30%.

Reported Earning Dates

BSX is expected to report earnings on Oct 22, 2025.

ICCM is expected to report earnings on Nov 25, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.81% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($144B) has a higher market cap than ICCM($66.5M). BSX YTD gains are higher at: 8.957 vs. ICCM (-12.364). BSX has higher annual earnings (EBITDA): 4.65B vs. ICCM (-15.54M). BSX has more cash in the bank: 534M vs. ICCM (5.38M). ICCM has less debt than BSX: ICCM (2.37M) vs BSX (12B). BSX has higher revenues than ICCM: BSX (18.5B) vs ICCM (2.79M).
BSXICCMBSX / ICCM
Capitalization144B66.5M216,541%
EBITDA4.65B-15.54M-29,889%
Gain YTD8.957-12.364-72%
P/E Ratio57.27N/A-
Revenue18.5B2.79M663,796%
Total Cash534M5.38M9,920%
Total Debt12B2.37M506,329%
FUNDAMENTALS RATINGS
BSX vs ICCM: Fundamental Ratings
BSX
ICCM
OUTLOOK RATING
1..100
553
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
8100
SMR RATING
1..100
64100
PRICE GROWTH RATING
1..100
6060
P/E GROWTH RATING
1..100
74100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICCM's Valuation (58) in the null industry is in the same range as BSX (81) in the Medical Specialties industry. This means that ICCM’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (8) in the Medical Specialties industry is significantly better than the same rating for ICCM (100) in the null industry. This means that BSX’s stock grew significantly faster than ICCM’s over the last 12 months.

BSX's SMR Rating (64) in the Medical Specialties industry is somewhat better than the same rating for ICCM (100) in the null industry. This means that BSX’s stock grew somewhat faster than ICCM’s over the last 12 months.

BSX's Price Growth Rating (60) in the Medical Specialties industry is in the same range as ICCM (60) in the null industry. This means that BSX’s stock grew similarly to ICCM’s over the last 12 months.

BSX's P/E Growth Rating (74) in the Medical Specialties industry is in the same range as ICCM (100) in the null industry. This means that BSX’s stock grew similarly to ICCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXICCM
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 5 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 14 days ago
45%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
58%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PUMXF0.130.01
+11.11%
Puma Exploration, Inc.
HAIUF11.10N/A
N/A
Healthcare AI Acquisition Corp.
WCHNF0.36N/A
N/A
West China Cement Ltd.
WPNTF6.20N/A
N/A
Warpaint London PLC
TSGTY30.86-2.64
-7.88%
Tsingtao Brewery Co., Ltd.

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+1.14%
ISRG - BSX
71%
Closely correlated
+2.11%
SYK - BSX
67%
Closely correlated
+1.12%
MMSI - BSX
56%
Loosely correlated
+2.12%
ALC - BSX
49%
Loosely correlated
+3.02%
PODD - BSX
49%
Loosely correlated
-0.99%
More

ICCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCM has been closely correlated with SINT. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICCM jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCM
1D Price
Change %
ICCM100%
-2.63%
SINT - ICCM
67%
Closely correlated
-4.14%
AMBFF - ICCM
45%
Loosely correlated
N/A
BSX - ICCM
32%
Poorly correlated
+1.14%
ILMN - ICCM
31%
Poorly correlated
+2.84%
PEN - ICCM
31%
Poorly correlated
+1.01%
More